Crestwood Advisors Group’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q3
Sell
-22,943
Closed -$780K 154
2015
Q2
$780K Sell
22,943
-256,091
-92% -$8.71M 0.1% 70
2015
Q1
$9.88M Buy
279,034
+29,921
+12% +$1.06M 1.41% 40
2014
Q4
$8.49M Buy
249,113
+14,213
+6% +$484K 1.28% 41
2014
Q3
$9.06M Sell
234,900
-56,544
-19% -$2.18M 1.42% 33
2014
Q2
$11.3M Buy
291,444
+4,719
+2% +$184K 1.81% 22
2014
Q1
$9.8M Buy
+286,725
New +$9.8M 1.6% 27